Table 2.
Control | Thbd-null | Thbd-null hmPC+ | hmPC+ | |
---|---|---|---|---|
d-dimer, median (IQR), ng/mL | 95 (86-139) (n = 15) | 135 (130-159) (P = .056) (n = 8) | 97 (81-145) (n.s.) (n = 8) | 95 (89-124) (n.s.) (n = 9) |
TAT, median (IQR), μg/L | 27 (15-81) (n = 10) | 74 (41-119) (n.s.) (n = 4) | 14 (13-17) (n.s.) (n = 8) | 23 (10-52) (n.s.) (n = 9) |
Fibrinogen, mean ± SD, % | 100 ± 16 (n = 5) | 51 ± 32 (p 0.011) (n = 6) | — | — |
IL-6, median (IQR), pg/mL | 19 (14-27) (n = 14) | 162 (60-369) (P = .0011) (n = 8) | 244 (69-320) (P = .0016) (n = 12) | 17 (13-88) (n.s.) (n = 9) |
Platelets, mean ± SD, × 109/L | 279 ± 81 (n = 12) | 223 ± 62 (n.s.) (n = 11) | — | — |
Hemoglobin, mean ± SD, g/dL | 13.0 ± 0.7 (n = 12) | 11.7 ± 0.5 (n.s.) (n = 11) | — | — |
White blood cells, mean ± SD, × 109/L | 6.3 ± 0.8 (n = 12) | 8.6 ± 1.3 (n.s.) (n = 11) | — | — |
Activated platelets, median (IQR), % P-selectin+ αIIbβ3+ | 0.030 (0.009-0.25) (n = 5) | 0.065 (0.040-0.077) (n.s.) (n = 5) | — | — |
Platelet leukocyte aggregates, median (IQR), % CD45/P-selectin+ or CD45/αIIbβ3+ | 10.9 (9.4-11.0) (n = 5) | 16.0 (12.2-19.0) (n.s.) (n = 5) | — | — |
Carotid injury thrombosis model | ||||
Time to occlusion, median (IQR), s | 189 (163-203) (n = 8) | 538 (394-899) (P = 0.0413) (n = 3) | 226 (160-355) (n.s.) (n = 8) | 276 (238-392) (P < 0.001) (n = 7) |
Controls comprised Thbd wild-type and ThbdloxP/+ C57black mice. Normally distributed parameters are presented as means and standard deviations; non–normally distributed parameters are presented as medians and IQRs.
hmPC+, mice expressing the PC transgene; IQR, interquartile range; n.s., nonsignificant; SD, standard deviation.